Prostate Specific Antigen (PSA) Test Global Market Report 2025

Description

The prostate-specific antigen (PSA) test is a blood test designed to measure the presence of prostate-specific antigen in the body. Its primary purpose is to screen for and monitor prostate cancer in men by assessing the levels of prostate-specific antigen in the bloodstream.

The main types of PSA tests include clinical laboratory improvement amendments (CLIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and others. Clinical laboratory improvement amendments (CLIA) comprise a set of regulations governing laboratory testing, requiring clinical laboratories to obtain certification from the Centers for Medicare & Medicaid Services (CMS) before conducting diagnostic testing on human samples. These tests find applications in various areas, including screening and post-treatment monitoring, and are utilized by diverse end-users such as hospitals, diagnostic centers, research institutes, and others.

The prostate-specific antigen (PSA) test market research report is one of a series of new reports from The Business Research Company that provides prostate-specific antigen (PSA) test market statistics, including prostate-specific antigen (PSA) test industry global market size, regional shares, competitors with a prostate-specific antigen (PSA) test market share, detailed prostate-specific antigen (PSA) test market segments, market trends and opportunities, and any further data you may need to thrive in the prostate-specific antigen (PSA) test industry. This prostate-specific antigen (PSA) test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prostate specific antigen (PSA) test market size has grown rapidly in recent years. It will grow from $4.15 billion in 2024 to $4.66 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased awareness, aging population, medical advancements, clinical recommendations, pharmaceutical advancements

The prostate specific antigen (PSA) test market size is expected to see rapid growth in the next few years. It will grow to $7.29 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to advancements in test accuracy, personalized medicine approach, personalized medicine approach, global aging population. Major trends in the forecast period include shift towards biomarker combinations, technological innovations, point-of-care testing, digital health integration, focus on early detection and prevention.

The projected expansion of the prostate-specific antigen (PSA) test market is fueled by the increasing incidence of prostate cancer. Prostate cancer, affecting the prostate gland in the male reproductive system, is a condition that warrants early detection and risk assessment. The PSA test serves as a prevalent screening tool for prostate cancer, measuring PSA levels in the bloodstream. Recent reports from the American Society of Clinical Oncology (ASCO) in March 2023 revealed that in the United States alone, an estimated 288,300 men were diagnosed with prostate cancer, with approximately 34,700 succumbing to the disease in 2023. Globally, it is anticipated that around 1,414,259 individuals will be diagnosed with prostate cancer in 2020. Consequently, the escalating prevalence of prostate cancer is a driving force behind the growth of the PSA test market.

The upswing in chronic diseases contributes to the burgeoning demand for PSA tests. Chronic diseases, characterized by prolonged medical conditions necessitating ongoing attention and management, include prostate cancer as one such condition. The PSA test emerges as a pivotal tool for screening, diagnosis, and monitoring the progression of prostate cancer. Predictions from the National Library of Medicine in 2022 anticipate a 99.5% rise in the number of individuals aged 50 and older with at least one chronic illness, reaching 142.66 million by 2050. Furthermore, the prevalence of multimorbidity is projected to increase by 91.16%, encompassing 14.968 million people in 2050. Hence, the upsurge in chronic diseases is poised to propel the PSA test market.

A prominent trend in the PSA test market is the integration of technological advancements. Key players in the market are actively developing advanced screening tools to maintain their competitive edge. LynxDx Inc., a US-based diagnostic company, exemplifies this trend with the launch of MyProstateScore 2.0 in February 2023. This non-invasive urine prostate cancer screening test employs 18 biomarkers, including the innovative gene fusion T2,ERG, for personalized risk assessment. MyProstateScore 2.0 not only delivers highly accurate, stratified risk assessment insights but also guides clinical decisions for patients exhibiting elevated PSA or abnormal digital rectal exam (DRE) findings.

Major companies in the PSA test market are focusing on product development and launches, such as home testing kits for PSA. Home testing kits, facilitating self-administered diagnostic procedures, offer convenience and accessibility. In September 2023, Randox, an Ireland-based health and toxicology company, unveiled an at-home testing kit for PSA. This kit enables individuals to measure PSA levels in their blood, providing indications of abnormalities within the prostate. Elevated PSA levels may signal various conditions, including an enlarged prostate, prostatitis, urinary tract infection, or the potential presence of prostate cancer.

In June 2024, AstraZeneca PLC, a biopharmaceutical company based in the UK, acquired Fusion Pharmaceuticals Inc. for an undisclosed sum. This acquisition is intended to enhance AstraZeneca PLC's advanced radioconjugate technology for more precise cancer treatments. Fusion Pharmaceuticals Inc. is a clinical-stage oncology company located in Canada that offers prostate-specific antigen (PSA) tests.

Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.

North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prostate specific antigen (psa) test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The prostate-specific antigen (PSA) test market includes revenues earned by entities by providing services such as prostate cancer detection, monitoring, PSA screening, prostatitis evaluation, complex PSA tests, and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prostate Specific Antigen (PSA) Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prostate specific antigen (psa) test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prostate specific antigen (psa) test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prostate specific antigen (psa) test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Clinical Laboratory Improvement Amendments (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Fluorescence Immunoassay (FIA); Other Types
2) By Application: Screening; Post-Treatment Monitoring; Other Applications
3) By End User: Hospitals; Diagnostic Centers; Research Institutes; Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests; Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits; Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA; Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA); Radioimmunoassay (RIA)
Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Bayer AG; Abbott Laboratories; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25242

1. Executive Summary

2. Prostate Specific Antigen (PSA) Test Market Characteristics

3. Prostate Specific Antigen (PSA) Test Market Trends And Strategies

4. Prostate Specific Antigen (PSA) Test Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Prostate Specific Antigen (PSA) Test Growth Analysis And Strategic Analysis Framework

5.1. Global Prostate Specific Antigen (PSA) Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prostate Specific Antigen (PSA) Test Market Growth Rate Analysis
5.4. Global Prostate Specific Antigen (PSA) Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prostate Specific Antigen (PSA) Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prostate Specific Antigen (PSA) Test Total Addressable Market (TAM)

6. Prostate Specific Antigen (PSA) Test Market Segmentation

6.1. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Laboratory Improvement Amendments (CLIA)
Enzyme-Linked Immunosorbent Assay (ELISA)
Fluorescence Immunoassay (FIA)
Other Types
6.2. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Screening
Post-Treatment Monitoring
Other Applications
6.3. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Research Institutes
Other End Users
6.4. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Clinical Laboratory Improvement Amendments (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CLIA Waived Tests
Non-CLIA Tests
6.5. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sandwich ELISA Kits
Competitive ELISA Kits
6.6. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Fluorescence Immunoassay (FIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Point-Of-Care FIA
Laboratory-Based FIA
6.7. Global Prostate Specific Antigen (PSA) Test Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemiluminescent Immunoassay (CLIA)
Radioimmunoassay (RIA)

7. Prostate Specific Antigen (PSA) Test Market Regional And Country Analysis

7.1. Global Prostate Specific Antigen (PSA) Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prostate Specific Antigen (PSA) Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prostate Specific Antigen (PSA) Test Market

8.1. Asia-Pacific Prostate Specific Antigen (PSA) Test Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prostate Specific Antigen (PSA) Test Market

9.1. China Prostate Specific Antigen (PSA) Test Market Overview
9.2. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prostate Specific Antigen (PSA) Test Market

10.1. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prostate Specific Antigen (PSA) Test Market

11.1. Japan Prostate Specific Antigen (PSA) Test Market Overview
11.2. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prostate Specific Antigen (PSA) Test Market

12.1. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prostate Specific Antigen (PSA) Test Market

13.1. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prostate Specific Antigen (PSA) Test Market

14.1. South Korea Prostate Specific Antigen (PSA) Test Market Overview
14.2. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prostate Specific Antigen (PSA) Test Market

15.1. Western Europe Prostate Specific Antigen (PSA) Test Market Overview
15.2. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prostate Specific Antigen (PSA) Test Market

16.1. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prostate Specific Antigen (PSA) Test Market

17.1. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prostate Specific Antigen (PSA) Test Market

18.1. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prostate Specific Antigen (PSA) Test Market

19.1. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prostate Specific Antigen (PSA) Test Market

20.1. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prostate Specific Antigen (PSA) Test Market

21.1. Eastern Europe Prostate Specific Antigen (PSA) Test Market Overview
21.2. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prostate Specific Antigen (PSA) Test Market

22.1. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prostate Specific Antigen (PSA) Test Market

23.1. North America Prostate Specific Antigen (PSA) Test Market Overview
23.2. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prostate Specific Antigen (PSA) Test Market

24.1. USA Prostate Specific Antigen (PSA) Test Market Overview
24.2. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prostate Specific Antigen (PSA) Test Market

25.1. Canada Prostate Specific Antigen (PSA) Test Market Overview
25.2. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prostate Specific Antigen (PSA) Test Market

26.1. South America Prostate Specific Antigen (PSA) Test Market Overview
26.2. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prostate Specific Antigen (PSA) Test Market

27.1. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prostate Specific Antigen (PSA) Test Market

28.1. Middle East Prostate Specific Antigen (PSA) Test Market Overview
28.2. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prostate Specific Antigen (PSA) Test Market

29.1. Africa Prostate Specific Antigen (PSA) Test Market Overview
29.2. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prostate Specific Antigen (PSA) Test Market Competitive Landscape And Company Profiles

30.1. Prostate Specific Antigen (PSA) Test Market Competitive Landscape
30.2. Prostate Specific Antigen (PSA) Test Market Company Profiles
- 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Prostate Specific Antigen (PSA) Test Market Other Major And Innovative Companies

31.1. PerkinElmer Inc.
31.2. Beckman Coulter Inc.
31.3. Bio-Rad Laboratories Inc.
31.4. Ortho-Clinical Diagnostics Inc.
31.5. DiaSorin SpA
31.6. OPKO Health Inc.
31.7. R&D Systems Inc.
31.8. Meso Scale Diagnostics LLC
31.9. Tosoh America Inc.
31.10. Fujirebio Europe N.V.
31.11. Boditech Med Inc.
31.12. DRG International Inc.
31.13. BioVision Inc.
31.14. Enzo Life Sciences Inc.
31.15. RayBiotech Inc.

32. Global Prostate Specific Antigen (PSA) Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prostate Specific Antigen (PSA) Test Market

34. Recent Developments In The Prostate Specific Antigen (PSA) Test Market

35. Prostate Specific Antigen (PSA) Test Market High Potential Countries, Segments and Strategies

35.1 Prostate Specific Antigen (PSA) Test Market In 2029 - Countries Offering Most New Opportunities
35.2 Prostate Specific Antigen (PSA) Test Market In 2029 - Segments Offering Most New Opportunities
35.3 Prostate Specific Antigen (PSA) Test Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer